AVNS
Avanos Medical, Inc. Healthcare - Medical Devices Investor Relations →
Avanos Medical, Inc. (AVNS) closed at $14.59 as of 2026-02-02, trading 28.4% below its 200-week moving average of $20.38. This places AVNS in the extreme value zone. The stock moved further from the line this week, up from -34.9% last week. With a 14-week RSI of 81, AVNS is in overbought territory.
Over the past 541 weeks of data, AVNS has crossed below its 200-week moving average 9 times. On average, these episodes lasted 42 weeks. The average one-year return after crossing below was -0.1%, suggesting these dips have not historically been reliable buying opportunities for this stock.
With a market cap of $677 million, AVNS is a small-cap stock. The company generates a free cash flow yield of 12.4%, which is notably high. Return on equity stands at -46.7%. The stock trades at 0.9x book value.
Management has been repurchasing shares, with a 4.7% reduction over three years. This stock also meets the Yartseva multibagger criteria as a small-cap with strong free cash flow yield and reasonable book value.
Over the past 10.5 years, a hypothetical investment of $100 in AVNS would have grown to $51, compared to $430 for the S&P 500. AVNS has returned -6.3% annualized vs 14.9% for the index, underperforming the broader market over this period.
In the past 12 months, corporate insiders have made 1 open-market purchase totaling $659,300. Notably, these purchases occurred while AVNS is trading below its 200-week moving average — insiders are buying when the market is most pessimistic.
Free cash flow has been growing at a 7.7% compound annual rate, with 4 consecutive years of positive cash generation. A business generating more cash every year while trading below its 200-week moving average is exactly the kind of disconnect value investors look for.
Growth of $100: AVNS vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After AVNS Crosses Below the Line?
Across 9 historical episodes, buying AVNS when it crossed below its 200-week moving average produced an average return of +0.4% after 12 months (median -15.0%), compared to +12.7% for the S&P 500 over the same periods. 44% of those episodes were profitable after one year. After 24 months, the average return was +14.1% vs +40.0% for the index.
Each line shows $100 invested at the moment AVNS crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
AVNS has crossed below its 200-week MA 9 times with an average 1-year return of +-0.1% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Sep 2015 | Aug 2016 | 44 | 37.9% | +20.3% | -49.3% |
| Sep 2016 | Nov 2016 | 10 | 10.9% | +31.2% | -58.2% |
| May 2017 | May 2017 | 2 | 0.6% | +47.7% | -59.7% |
| Dec 2018 | Jan 2019 | 1 | 4.1% | -14.9% | -63.4% |
| Mar 2019 | Mar 2019 | 1 | 1.3% | -48.3% | -64.3% |
| May 2019 | Jun 2019 | 3 | 9.3% | -31.5% | -64.5% |
| Jul 2019 | Oct 2019 | 14 | 22.2% | -17.1% | -63.6% |
| Nov 2019 | Nov 2020 | 54 | 50.6% | +11.9% | -58.9% |
| May 2021 | Ongoing | 249+ | 53.0% | Ongoing | -64.5% |
| Average | 42 | — | +-0.1% | — |
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of Friday close, 2026-02-02